Zaynich Injection, Powder, For Solution
NDC Package 87706-866-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Zaynich (zidebactam dihydrate and cefepime hydrochloride) injection is zAYNICH is contraindicated in patients with a known history of serious hypersensitivity to the components of ZAYNICH (cefepime and zidebactam) or other beta-lactam antibacterial drugs [ see Warnings and Precautions ( 5.1) ]. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Wockhardt Suisse Usa Llc, this product is identified by NDC 87706-866 and is authorized under FDA application NDA220787.

Identification & Billing

NDC Package Code
87706-866-01
Package Description
1 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (87706-866-00)
Product Code
87706-866
11-Digit Billing Format
87706086601

Clinical Specifications

Proprietary Name
Zaynich
Non-Proprietary Name
Zidebactam Dihydrate And Cefepime Hydrochloride
Substance Name
Cefepime Hydrochloride; Zidebactam Dihydrate
Dosage Form
Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
ZAYNICH is contraindicated in patients with a known history of serious hypersensitivity to the components of ZAYNICH (cefepime and zidebactam) or other beta-lactam antibacterial drugs [ see Warnings and Precautions ( 5.1) ].

Regulatory & Marketing

Labeler Name
Wockhardt Suisse Usa Llc
Product Type
Human Prescription Drug
FDA Application #
NDA220787
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-29-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87706-866-01 identifies a specific commercial package of 1 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose (87706-866-00) of Zaynich, a human prescription drug labeled by Wockhardt Suisse Usa Llc. This injection, powder, for solution is formulated for intravenous use and contains cefepime hydrochloride; zidebactam dihydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wockhardt Suisse Usa Llc on May 29, 2026. The current certification is valid through December 31, 2027.

How is this Wockhardt Suisse Usa Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87706086601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87706-866-01
11-Digit CMS (5-4-2)
87706-0866-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.